| abstract |
The invention relates generally to methods of synthesizing polypeptides and intermediates thereof, and fragments, variants and derivatives thereof, having insulin agonist activity, related compositions and formulations and their preparation and use, and methods for the prevention and treatment of conditions, diseases and disorders that would be improved, eased, or lessened by the administration of a composition of the invention, including but not limited to glucose metabolism diseases. |